Companies: 10,795·Total market cap: $144.5T

Tempest Therapeutics, Inc.

Tempest Therapeutics, Inc.

TPSTNASDAQHealthcare● Active

$1.27

+$0.00(+0.00%)

Market Cap$5639940

P/E Ratio—

52W High$12.23

52W Low$1.23

Avg Volume207K

Open$1.28

Beta-1.69

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Tempest Therapeutics, Inc.（TPST）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · TPST · 截至 Jun 9, 2026

关键指标

EPS (TTM)—Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)—Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding—Shares outstanding history

Next EarningsTBAEarnings history

探索 Tempest Therapeutics, Inc. 数据

分析师预测—

股息不分红

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Tempest Therapeutics, Inc.

$1.27+0.00%$5.6M #2

Aligos Therapeutics, Inc.

$4.96+5.04%$30.7M #3

Actinium Pharmaceuticals, Inc.

$1.06+0.95%$33.3M #4

Barinthus Biotherapeutics plc

$0.72+2.49%$29.4M #5

$9.07-1.63%$36.7M #6

INmune Bio, Inc.

$1.24+3.63%$33.0M

关于 Tempest Therapeutics, Inc.

CEOMatthew Angel

IPO DateNov 12, 2012

Employees24

CountryUS

Websitetempesttx.com

Tempest Therapeutics, Inc. Tempest Therapeutics Inc. is an oncology company, currently in the clinical development phase, dedicated to advancing novel small molecule drugs designed to combat cancer. The firm's pipeline highligh…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Tempest Therapeutics, Inc.（TPST）是 Biotechnology 行业的 Healthcare 类公司，于 Nov 12, 2012 在 NASDAQ 上市。截至最近交易日，TPST 股价为 $1.27，市值约为 $5.6M。过去12个月累计回报 —，年初至今回报 —。

常见问题

截至最近一个交易日，Tempest Therapeutics, Inc.（TPST）股价为 $1.27，在 NASDAQ 上市，52周区间为 $1.23 – $12.23。

TPST 最新股价TPST quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议